Pierre-Marie Roy Selected Research

Pierre-Marie Roy Research Topics

Disease

31	Pulmonary Embolism 06/2023 - 09/2002
10	Venous Thromboembolism 11/2023 - 03/2004
10	Venous Thrombosis (Deep-Vein Thrombosis) 11/2023 - 03/2004
6	Hemorrhage 07/2022 - 08/2019
4	Neoplasms (Cancer) 01/2023 - 01/2006
3	Thrombosis (Thrombus) 11/2023 - 04/2015
3	Myocardial Infarction 12/2022 - 10/2018
3	ST Elevation Myocardial Infarction 12/2022 - 01/2021
3	Chest Pain (Chest Pains) 12/2022 - 10/2018
3	Cardiovascular Diseases (Cardiovascular Disease) 12/2022 - 10/2018
3	Thromboembolism 01/2022 - 04/2005
2	Critical Illness (Critically Ill) 06/2023 - 04/2005
2	COVID-19 06/2023 - 08/2021
2	Acute Coronary Syndrome 01/2021 - 10/2018
1	Chronic Obstructive Pulmonary Disease (COPD) 11/2023
1	Obesity 06/2023
1	Infections 06/2023
1	Hypothyroidism 11/2022
1	Postthrombotic Syndrome 07/2022
1	Wounds and Injuries (Trauma) 01/2021
1	Hematoma 01/2021
1	Urticaria (Hives) 01/2019
1	Hemoptysis 01/2019
1	Disseminated Intravascular Coagulation 12/2018
1	Hypotension (Low Blood Pressure) 08/2012
1	Shock 08/2012
1	Tinnitus 02/2007
1	Headache (Headaches) 02/2007
1	Nausea 02/2007
1	Photophobia (Light Sensitivity) 02/2007
1	Lung Diseases (Lung Disease) 02/2006
1	Heart Failure 02/2006
1	Fever (Fevers) 01/2006
1	Esophagitis 04/2005
1	Gastroesophageal Reflux (GERD) 04/2005

Drug/Important Bio-Agent (IBA)

23	fibrin fragment D (D-dimer)IBA 11/2023 - 03/2004
12	AnticoagulantsIBA 01/2022 - 01/2006
5	TroponinIBA 12/2022 - 08/2012
5	Biomarkers (Surrogate Marker)IBA 11/2022 - 08/2012
3	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 11/2023 - 12/2018
2	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2023 - 01/2022
2	Dalteparin (Dalteparin Sodium)FDA Link 07/2022 - 01/2022
2	Enoxaparin (Lovenox)FDA LinkGeneric 07/2022 - 07/2011
2	Warfarin (Coumadin)FDA LinkGeneric 07/2022 - 07/2021
2	edoxabanIBA 07/2022 - 07/2021
2	omega-Chloroacetophenone (Mace)IBA 08/2021 - 10/2018
2	Fibrinolytic Agents (Antithrombotic Agents)IBA 01/2021 - 08/2019
2	Natriuretic PeptidesIBA 06/2013 - 08/2012
1	cupric sulfide (CuS)IBA 01/2023
1	factor AIBA 01/2023
1	Thyrotropin (Thyroid-Stimulating Hormone)FDA Link 11/2022
1	Tinzaparin (Innohep)FDA Link 07/2022
1	Nadroparin (Nadroparin Calcium)IBA 07/2022
1	Fondaparinux (Arixtra)FDA Link 07/2022
1	RivaroxabanIBA 01/2022
1	Oxygen (Dioxygen)IBA 08/2021
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 08/2021
1	Vitamin K FDA Link 12/2020
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2020
1	Dabigatran FDA Link 01/2020
1	idarucizumabIBA 01/2020
1	GlucocorticoidsIBA 01/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Histamine Antagonists (Antihistamines)IBA 01/2019
1	levocetirizine FDA LinkGeneric 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 06/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 06/2013
1	LatexIBA 07/2005
1	ImmunosorbentsIBA 03/2004
1	EnzymesIBA 03/2004
1	ElementsIBA 09/2002

Therapy/Procedure

3	Therapeutics 01/2022 - 06/2006
2	Ambulatory Care (Outpatient Care) 07/2011 - 11/2008
1	Hospice Care (Care, Bereavement) 01/2021
1	Critical Care (Surgical Intensive Care) 01/2021
1	Operative Surgical Procedures 01/2020
1	Vena Cava Filters (Inferior Vena Cava Filter) 04/2015
1	Contraindications 08/2012
1	Thrombolytic Therapy 08/2012
1	Punctures 02/2007
1	Bed Rest (Bedrest) 02/2007
1	Gastrostomy 04/2005